About this trial
Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
American Society of Anesthesiology physical status of I or III (ASA), of both sex
cancer-related anal or perineal pain
Disqualifiers
coagulopathies
allergies to the contrast dye
patients with moderate or significant cardiac/respiratory disease or hepatic
Trial design
Parallel
Treatments tested in this trial
US assisted caudal epidural pulsed radiofrequency
Procedure/Surgerypatients will receive US assisted caudal epidural pulsed radiofrequency and followed up to 8 weeks
Treatment groups
Trial outcomes
Primary outcomes
visual analog scale (VAS) score 4 weeks post-intervention
Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks
Sponsors and contacts
Click on the lead sponsor to view all of their trials.